Esophageal cancer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 62: Line 62:
Among patients with histologically confirmed cases of invasive esophageal cancer, the percent distribution of the types of the disease between 2007 and 2011 in the United States are:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
Among patients with histologically confirmed cases of invasive esophageal cancer, the percent distribution of the types of the disease between 2007 and 2011 in the United States are:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
*  [[Carcinoma]]: 99.1%
*  [[Carcinoma]]: 99.1%
** [[Epidermoid carcinoma]]: 33.7%
:* [[Epidermoid carcinoma]]: 33.7%
*** [[Squamous cell carcinoma]]: 33.6%
::: 1. [[Squamous cell carcinoma]]: 33.6%
** [[Adenocarcinoma]]: 60.7%
::: 2. [[Transitional cell carcinoma]]
** Other specific carcinoma: 1.5%
::: 3. [[Basal cell carcinoma]]
** Carcinoma not otherwise specified: 3.2%
:* [[Adenocarcinoma]]: 60.7%
:* Other specific carcinoma: 1.5%
:* Carcinoma not otherwise specified: 3.2%
* Other specific types: 0.3%
* Other specific types: 0.3%
* Unspecified: 0.6%
* Unspecified: 0.6%

Revision as of 15:01, 13 August 2015

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer epidemiology and demographics

CDC on Esophageal cancer epidemiology and demographics

Esophageal cancer epidemiology and demographics in the news

Blogs on Esophageal cancer epidemiology and demographics

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Compared to other malignancies, cancer of the esophagus and the gastroesophageal junction is relatively infrequent and ranks as the 8th most common type of cancer.[1] The epidemiology of esophageal carcinoma reflects a geographical distribution of the disease in terms of incidence and histopathological type. In fact, esophageal cancer is most common in the area of the “Asian belt” which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.[1] Worldwide, the predominant type of esophageal cancer is squamous cell carcinoma. However, the rate of adenocarcinoma outnumbers squamous cell carcinoma in the Unites States and some European countries.[2] The incidence of adenocarcinoma has been increasing, a finding that can be attributed to the increase in the rate of Barrett's esophagus. Moreover, while squamous cell carcinoma is more common among black individuals, adenocarcinoma is more common among white people.[2] In 2011, the age-adjusted incidence of invasive esophageal cancer was 4.45 per 100,000 persons in the United States.[3] The estimated number of new cases in the United States in 2014 is 18.170.[4]

Epidemiology and Demographics

Prevalence

  • The prevalence of esophageal cancer differs among countries. In fact, esophageal cancer is most common in area of the “Asian belt” which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.[1]
  • In the United States, the age-adjusted prevalence of invasive esophageal cancer is 8.6 per 100.000 in 2011.[3]

Incidence

  • The delay-adjusted incidence of invasive esophageal cancer in 2011 was estimated to be 4.51 per 100,000 persons in the United States.[3]
  • In 2011, the age-adjusted incidence of invasive esophageal cancer was 4.45 per 100,000 persons in the United States.[3]

Age

  • The risk of esophageal cancer increases with age. While the overall age-adjusted incidence of invasive esophageal cancer in the United States between 2007 and 2011 is 4.4 per 100,000, the age-adjusted incidence of invasive esophageal cancer by age category is:[3]
    • Under 65 years: 1.8 per 100,000
    • 65 and over: 22.5 per 100,000

Gender

  • In the United States, the age-adjusted prevalence of invasive esophageal cancer by gender in 2011 is:[3]
    • In males: 0.0147%
    • In females: 0.0036%
  • In the United States, the delay-adjusted incidence of invasive esophageal cancer by gender in 2011 is:[3]
    • In males: 7.83 per 100,000 persons
    • In females: 1.83 per 100,000 persons
  • In the United States, the age-adjusted incidence of invasive esophageal cancer by gender on 2011 is:[3]
    • In males: 7.72 per 100,000 persons
    • In females: 1.80 per 100,000 persons

Shown below is an image depicting the delay-adjusted incidence and observed incidence of invasive esophageal cancer by gender and race in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[3]

Delay-adjusted incidence and observed incidence of invasive esophageal cancer by gender and race in the United States between 1975 and 2011

Race

  • While squamous cell carcinoma is more common among black individuals, adenocarcinoma is more common among white people.[2] In the United States, 68.5% of white subjects with esophageal cancer had adenocarcinoma, whereas 80% of black individuals affected with esophageal cancer had squamous cell carcinoma between 2007 and 2011.[3]


  • Shown below is a table depicting the age-adjusted prevalence of invasive esophageal cancer by race in 2011 in the United States.[3]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 8.6 per 100,000 9.4 per 100,000 7 per 100,000 4.7 per 100,000 4.8 per 100,000

Shown below is an image depicting the incidence of invasive esophageal cancer by race in the United States between 1975 and 2011.[3]

Incidence of invasive esophageal cancer by race in the United States between 1975 and 2011

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

Percent Distribution of Invasive Esophageal Cancer by Histology

Among patients with histologically confirmed cases of invasive esophageal cancer, the percent distribution of the types of the disease between 2007 and 2011 in the United States are:[3]

1. Squamous cell carcinoma: 33.6%
2. Transitional cell carcinoma
3. Basal cell carcinoma
  • Adenocarcinoma: 60.7%
  • Other specific carcinoma: 1.5%
  • Carcinoma not otherwise specified: 3.2%
  • Other specific types: 0.3%
  • Unspecified: 0.6%

References

  1. 1.0 1.1 1.2 Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013). "Oesophageal carcinoma". Lancet. 381 (9864): 400–12. doi:10.1016/S0140-6736(12)60643-6. PMID 23374478.
  2. 2.0 2.1 2.2 Zhang Y (2013). "Epidemiology of esophageal cancer". World J Gastroenterol. 19 (34): 5598–606. doi:10.3748/wjg.v19.i34.5598. PMC 3769895. PMID 24039351.
  3. 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  4. Cancer.gov


Template:WikiDoc Sources